Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine in Total Hip Arthroplasty
NCT07226700Phase 3Recruiting
- Sponsor
- Hospital for Special Surgery
- Start
- Nov 2025
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of suzetrigine in postoperative pain, sponsored by Hospital for Special Surgery. Started Nov 2025; status: recruiting.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07226700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07226700.